6 companies lead medical device start-up’s $312m SPAC merger

ByLance T. Lee

Aug 23, 2022
By Tom Zanki (August 23, 2022, 3:31 p.m. EDT) – Medical device company Biolog-id and special-purpose acquisition company Genesis Growth Tech Acquisition Corp. announced on Tuesday that they had agreed to a merger, guided by six law firms, that would take Biolog-id public at a net worth of $312 million.

The two parties have entered into a memorandum of understanding laying the groundwork for the merger, which is expected to be completed by the first quarter of 2023. Shares of Biolog-id are expected to trade on the Nasdaq under the symbol “BGID” once the transaction concluded.

Mintz Levin Cohn Ferris Glovsky and Popeo PC, Charles Russell Speechlys LLP and Carey Olsen are legal counsel…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!

TRY LAW360 FREE FOR SEVEN DAYS


Source link